Description
Discover free excerpts of our full report on Pricing & Reimbursement in Germany. This excerpt will provide sample content on:
- Key stakeholders in the German retail & hospital market
- Benefit assessment process in Germany
- Pricing and Reimbursement timelines in Germany
- Extra funding pathways
- Illustrative analogue cases showcasing HTA assessments by the G-BA and price outcomes for specific medicines and therapeutic areas
For complete information please refer to the full report Germany Pricing and Reimbursement: Paradise for Orphan Drugs
